Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02987829
Brief Title: Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

First Submitted : December 5, 2016
First Submitted that Met QC Criteria : December 8, 2016
First Posted : December 9, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 18, 2018
Last Update Posted : October 19, 2018